These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2808193)

  • 1. How predictable is development of resistance after beta-lactam therapy in Enterobacter cloacae infection?
    Michéa-Hamzehpour M; Pechère JC
    J Antimicrob Chemother; 1989 Sep; 24(3):387-95. PubMed ID: 2808193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Beta-lactam resistance in aquatic Enterobacter cloacae strains using phenotypic and genotypic criteria].
    Lazăr V; Cernat R; Balotescu C; Cotar A; Coipan E; Cojocaru C
    Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):185-91. PubMed ID: 15085610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of beta-lactam-resistant Enterobacter cloacae in mice.
    Marchou B; Michea-Hamzehpour M; Lucain C; Pechère JC
    J Infect Dis; 1987 Aug; 156(2):369-73. PubMed ID: 3598235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dosing and dosing frequency on the efficacy of ceftizoxime and the emergence of ceftizoxime resistance during the early development of murine abscesses caused by Bacteroides fragilis and Enterobacter cloacae mixed infection.
    Stearne LE; Goessens WH; Mouton JW; Gyssens IC
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3605-11. PubMed ID: 17646416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-lactamase expression and cross-resistance to beta-lactam antibiotics in a nosocomial population of Enterobacter.
    Steffee CH; Wasilauskas BL
    Chemotherapy; 1992; 38(5):291-6. PubMed ID: 1286572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Failure of new beta-lactam antibiotics in the treatment of severe Enterobacter cloacae infections].
    Perronne C; Régnier B; Legrand P; Buré A; Frottier J; Vildé JL; Vachon F
    Presse Med; 1986 Oct; 15(36):1813-8. PubMed ID: 2947158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of antimicrobial susceptibility for β-lactams against clinical isolates from 51 medical centers in Japan (2008).
    Ishii Y; Ueda C; Kouyama Y; Tateda K; Yamaguchi K
    Diagn Microbiol Infect Dis; 2011 Apr; 69(4):443-8. PubMed ID: 21396543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection frequency of resistant variants by various beta-lactam antibiotics in clinical Enterobacter cloacae isolates.
    Büscher KH; Cullmann W; Dick W; Stieglitz M
    Chemotherapy; 1987; 33(1):40-51. PubMed ID: 3493886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of beta-lactamase hydrolysis and outer membrane permeability to ceftriaxone resistance in Enterobacter cloacae.
    Marchou B; Bellido F; Charnas R; Lucain C; Pechère JC
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1589-95. PubMed ID: 3501699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of resistance during ceftazidime and cefepime therapy in a murine peritonitis model.
    Pechère JC; Vladoianu IR
    J Antimicrob Chemother; 1992 May; 29(5):563-73. PubMed ID: 1624394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance emerging after pefloxacin therapy of experimental Enterobacter cloacae peritonitis.
    Lucain C; Regamey P; Bellido F; Pechére JC
    Antimicrob Agents Chemother; 1989 Jun; 33(6):937-43. PubMed ID: 2548441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of resistance during beta-lactam therapy of gram-negative infections. Bacterial mechanisms and medical responses.
    Pechère JC
    Drugs; 1988; 35 Suppl 2():22-8. PubMed ID: 3260854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility to 19 agents other than β-lactams among third-generation cephalosporin-resistant Enterobacteriaceae recovered on hospital admission.
    Mischnik A; Baumert P; Hamprecht A; Rohde AM; Peter S; Feihl S; Knobloch J; Gölz H; Kola A; Obermann B; Querbach C; Willmann M; Gebhardt F; Tacconelli E; Gastmeier P; Seifert H; Kern WV;
    J Antimicrob Chemother; 2017 May; 72(5):1359-1363. PubMed ID: 28108677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors that influence the evolution of beta-lactam resistance in beta-lactamase-inducible strains of Enterobacter cloacae and Pseudomonas aeruginosa.
    Aronoff SC; Shlaes DM
    J Infect Dis; 1987 May; 155(5):936-41. PubMed ID: 3104483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic resistance in Enterobacter cloacae strains with derepressed/partly derepressed/inducible AmpC and extendedspectrum beta-lactamases in Zenica-Doboj Canton, Bosnia and Herzegovina.
    Uzunović S; Ibrahimagić A; Bedenić B
    Med Glas (Zenica); 2018 Feb; 15(1):37-45. PubMed ID: 29214986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamases.
    Jones RN; Craig WA; Ambrose PG; Dudley MN; Pottumarthy S
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):235-46. PubMed ID: 16105568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
    Burgess DS; Frei CR
    J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of ceftazidime dose regimen on the selection of resistant Enterobacter cloacae in the intestinal flora of rats treated for an experimental pulmonary infection.
    Goessens WH; Mouton JW; ten Kate MT; Bijl AJ; Ott A; Bakker-Woudenberg IA
    J Antimicrob Chemother; 2007 Mar; 59(3):507-16. PubMed ID: 17289765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group.
    Spencer RC
    Scand J Infect Dis Suppl; 1993; 91():25-32. PubMed ID: 8290900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of resistance to ceftazidime during therapy for Enterobacter cloacae infections.
    Quinn JP; DiVincenzo CA; Foster J
    J Infect Dis; 1987 May; 155(5):942-7. PubMed ID: 3549922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.